Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Gross Margin (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Gross Margin for 2 consecutive years, with 78.37% as the latest value for Q4 2025.

  • Quarterly Gross Margin changed N/A to 78.37% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 82.77% through Dec 2025, down 1429.0% year-over-year, with the annual reading at 82.77% for FY2025, 1429.0% down from the prior year.
  • Gross Margin for Q4 2025 was 78.37% at Pyxis Oncology, down from 100.0% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q2 2025, with the low at 78.37% in Q4 2025.